Atherosclerosis and inflammation

Related Experiment Video

Updated: Sep 26, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

John A Farmer1, Guillermo Torre-Amione

  • 1Section of Cardiology, Baylor College of Medicine, Ben Taub General Hospital, One Baylor Plaza, Room 525D, Houston, TX 77030, USA. jfarmer@bcm.tmc.edu

Current Atherosclerosis Reports
|February 2, 2002
PubMed

Insights

Inflammation plays a key role in coronary atherosclerosis, a complex heart disease. New clinical markers of inflammation may improve the prediction of heart disease risk beyond traditional factors.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Biochemistry

Background:

  • Coronary atherosclerosis is a complex, multifactorial disease.
  • Traditional risk factors (hypertension, diabetes, etc.) have limitations in predicting individual patient risk.
  • Atherosclerosis is increasingly recognized as an inflammatory process.

Purpose of the Study:

  • To review inflammation as a potential pathogenetic factor in atherosclerosis.
  • To explore the role of clinical inflammation markers in patient risk identification.

Main Methods:

  • Literature review focusing on the role of inflammation in atherosclerosis.
  • Analysis of emerging clinical markers of inflammation.
  • Evaluation of prognostic information provided by these markers.

Main Results:

  • Evidence supports inflammation's central role from early lesions to vulnerable plaques.
  • Clinical markers like C-reactive protein and modified LDL show promise.
  • These markers may offer additional prognostic value in managing patients.

Conclusions:

  • Inflammation is a critical factor in the pathogenesis of coronary atherosclerosis.
  • Clinical markers of inflammation can enhance risk stratification for cardiovascular disease.
  • Further research into these markers can improve patient management and outcomes.

More Related Videos

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis09:55

Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis

Published on: October 25, 2024

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...